小丑 发表于 2025-3-25 05:13:43

http://reply.papertrans.cn/2/185/18449/18449-21.png

Mere仅仅 发表于 2025-3-25 08:50:15

http://reply.papertrans.cn/2/185/18449/18449-22.png

预防注射 发表于 2025-3-25 13:44:08

Submitted on: 15 May 1999.
Revised on: 30 June 1999.
Accepted on: 14 August 1999.

___________________JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Original 发表于 2025-3-25 19:05:20

Submitted on: 25 September 2016.
Revised on: 24 October 2016.
Accepted on: 08 December 2016.

___________________JOURNAL OF ONCOLOGY PHARMACY PRACTICE

PON 发表于 2025-3-25 21:31:05

http://reply.papertrans.cn/2/185/18449/18449-25.png

Figate 发表于 2025-3-26 03:33:51

http://reply.papertrans.cn/2/185/18449/18449-26.png

HEW 发表于 2025-3-26 07:55:16

http://reply.papertrans.cn/2/185/18449/18449-27.png

motivate 发表于 2025-3-26 08:59:22

http://reply.papertrans.cn/2/185/18449/18449-28.png

Ophthalmologist 发表于 2025-3-26 15:37:41

http://reply.papertrans.cn/2/185/18449/18449-29.png

Mobile 发表于 2025-3-26 17:28:20

Submitted on: 06 May 2013.
Revised on: 26 July 2013.
Accepted on: 04 September 2013.

___________________JOURNAL OF ONCOLOGY PHARMACY PRACTICE
页: 1 2 [3] 4
查看完整版本: SCIE期刊JOURNAL OF ONCOLOGY PHARMACY PRACTICE 2024/2025影响因子:1.147 (J ONCOL PHARM PRACT) (1078-1552). (ONCOLOGY)(肿瘤学)Scien